Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805373 · ClinicalTrials.gov registry record
Validation of a Diet Risk Screening Tool
A clinical trial, sponsored by Penn State University.
- Completed
- Registry status
- 125
- Enrollment target
NCT03805373: Completed study, sponsored by Penn State University.
NCT03805373 is a clinical trial that has completed, run by Penn State University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03805373 has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) is responsible for 1 in 4 deaths in the US annually. Nutrition is an important part of prevention and management of CVD and other chronic diseases, but only about 25% of patients with a chronic disease diagnosis (and about 12% of patients without a chronic disease) receive nutrition counseling from their physician. The investigators plan to validate a diet questionnaire in preparation for the creation of a diet assessment/ intervention tool to increase rates of nutrition intervention in medical care. The aim of this project is to test whether the developed questionnaire accurately identifies individuals at high nutritional risk compared to the Healthy Eating Index- 2015 (HEI-2015) determined by a validated questionnaire.
Primary Outcome
Assess the agreement between DRS (scored out of 27) and HEI-2015 (scored out of 100 points) calculated from Viocare Food Frequency Questionnaire (FFQ)
Interventions
- OTHER Diet Assessment Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-12-31 |
What the finished NCT03805373 record still lists
NCT03805373 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diet Assessment Survey is the first listed.
NCT03805373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03805373 about?
NCT03805373 is a clinical study titled "Validation of a Diet Risk Screening Tool". Cardiovascular disease (CVD) is responsible for 1 in 4 deaths in the US annually. Nutrition is an important part of prevention and management of CVD and other chronic diseases, but only about 25% of patients with a chronic disease diagnosis (and about 12% of patients without a chronic disease) recei...
What is the current status of trial NCT03805373?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2019-01-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03805373?
The interventions under investigation include: Diet Assessment Survey (OTHER).
Who is sponsoring clinical trial NCT03805373?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI